Outcome of 232 Morbidly Obese Patients Treated with Laparoscopic Adjustable Gastric Banding between 1995–2003

Abstract

Background: Laparoscopic adjustable gastric banding (LAGB) is widely used for the treatment of morbidly obese patients. We prospectively evaluated the effect of LAGB since 1995. Methods: Between March 1995 and August 2003, 232 morbidly obese patients underwent LAGB. The pars flaccida technique was used in the majority of the patients. Data were prospectively collected. Results: The median age was 35 years and 93% were female. Initial median body weight was 129 kg with a median BMI of 46. After 5 years of follow-up, median BMI decreased to 36 and the median body weight decreased to 98 kg. Median excess weight loss was 37% after 1 year, 42% after 3 years and 42% after 5 years of follow-up. Late postoperative complications were pouch dilatation (n = 33), port revision (n = 19), erosion (n = 4) and necrosis (n = 1). Conclusion: LAGB is a safe and successful treatment for patients with morbid obesity. Maximal weight reduction is achieved within 12 months and remains stable up to at least 5 years. These results suggest that LAGB could have a positive outcome on morbid obesity-associated morbidity and overall life expectancy.

Emergency gastrectomy for gastric necrosis 5 years after laparoscopic adjustable gastric banding (LAGB)

“…Therefore, early detection of gastric necrosis is crucial to satisfactory patient management. The reported data of follow-up periods following LAGB are generally less than five years [4]. As gastric necrosis can occur as a late delayed complication (after five years) as seen in this reported case, a more vigilant long term follow-up of LAGB cases is recommended.…”

“…All papers relevant to this study were reviewed and of these, 22 papers have been included in this study. The findings of the cases with gastric necrosis following LAGB including details of : a) reference #, b) author, c) study type, d) number of cases/patients reported, e) age and sex, f) time interval between LAGB and gastric necrosis, g) presenting symptoms, h) management, i) outcome and j) cause of the gastric necrosis are summarized in Table 1 [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16].…”

“…Since its introduction in 1993 and approval by the Foods and Drug Administration in 2001, Laparoscopic Adjustable Gastric Banding (LAGB) has gained popularity for the treatment of morbid obesity, making it one of the most common surgeries in Europe, Australia, Latin America, and the USA [4,5]. The ease of this surgical technique coupled with the minimal invasiveness and its reversibility has contributed to its increasing popularity over the past five years [2].…”